MCMedicalCodingSoftware
Free trial
X2R50WA

X2R50WA: Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10

Billable / specific codeICD-10-PCS

CMS abbreviated title: Replace RUE Art w Bioeng Hum Acelr Vsl, Open, New Tech 10

How X2R50WA is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology: What family of procedure this is
  2. 2Body systemWhich system it acts on
  3. RRoot operationThe objective: the verb of the procedure
  4. 5Body partThe specific site
  5. 0ApproachHow the site was reached
  6. WDeviceWhat was left in place, if anything
  7. AQualifierA further distinction where one applies

Codes near X2R50WA

In CMS’s own ordering, which groups codes that differ by only the last character or two, usually the approach, device or qualifier.

  • X2K00FBBypass Inferior Vena Cava using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11
  • X2KA30ABypass Left Atrium using Conduit through Coronary Sinus to Right Atrium, Percutaneous Approach, New Technology Group 10
  • X2KG0FBBypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11
  • X2KH3D9Bypass Right Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
  • X2KH3E9Bypass Right Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
  • X2KJ3D9Bypass Left Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
  • X2KJ3E9Bypass Left Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
  • X2R50WAReplacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2R60WAReplacement of Left Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2R70WAReplacement of Right Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2R80WAReplacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
  • X2RF3LCReplacement of Aortic Valve using Zooplastic Tissue, with Integrated Native Leaflet Clipping Locators, Percutaneous Approach, New Technology Group 12
  • X2RG3FCReplacement of Mitral Valve with Balloon-expandable Bioprosthetic Valve with Dock, Percutaneous Approach, New Technology Group 12
  • X2RH0GCReplacement of Pulmonary Valve using Size-Adjustable Synthetic Substitute, Open Approach, New Technology Group 12
  • X2RJ3RAReplacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10
  • X2RX0N7Replacement of Thoracic Aorta, Arch using Branched Synthetic Substitute with Intraluminal Device, Open Approach, New Technology Group 7
ICD-10-PCSFY2027